NL
ABMD

NVWM LLC’s Abiomed Inc ABMD Stock Holding History

NVWM LLC’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40
Closed -$7K – 394
2019
Q4 		$7K Hold
40
– – ﹤0.01% 258
2019
Q3 		$7K Hold
40
– – ﹤0.01% 289
2019
Q2 		$10K Sell
40
-1,575
-98% -$418K 0.01% 286
2019
Q1 		$461K Sell
1,615
-746
-32% -$248K 0.31% 111
2018
Q4 		$767K Hold
2,361
– – 0.57% 54
2018
Q3 		$1.06M Buy
2,361
+77
+3% +$30.4K 0.67% 47
2018
Q2 		$934K Hold
2,284
– – 0.65% 49
2018
Q1 		$637K Buy
2,284
+50
+2% +$12.7K 0.46% 66
2017
Q4 		$419K Buy
+2,234
New +$417K 0.32% 101

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

NVWM LLC's ABMD Position: Q1 2020 in Review

NVWM LLC sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 40 shares — an estimated $7K sold.

NVWM LLC first reported a position in ABMD in Q4 2017 and held it in 9 quarters. The position peaked at $1.06M in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • NVWM LLC reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • NVWM LLC sold 40 Abiomed Inc shares in Q1 2020, an estimated $7K.
  • NVWM LLC first reported a position in Abiomed Inc in Q4 2017 and held it in 9 quarters.
  • NVWM LLC's Abiomed Inc position peaked at $1.06M in Q3 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on NVWM LLC's 13F filing for Q1 2020, filed 8 May 2020.